on 16 Dec 2020
Last Applicant/ Owned by
Epsilogen Ltd
The London Bioscience Innovation Centre, 2 Royal College Street
LONDON, , NW1 0NH
Serial Number
UK00003568803 filed on 16th Dec 2020
Registration Number
UK00003568803 registered on
23rd Apr 2021
Correspondent Information
Cooley (UK) LLP
22 Bishopsgate
London,
EC2N 4BQ
Pharmaceutical preparations; pharmaceutical drugs; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for medical purposes; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine; diagnostic reagents for medical laboratory use.
Development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; research, development and production of pharmaceuticals in the fields of oncology, immunology and immuno-oncology; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies; research and development in the field of recombinant proteins and antibodies for therapeutic and prophylactic use; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new therapeutic proteins and antibodies; development of pharmaceuticals, pharmaceutical ingredients, and antibodies; developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical services, namely, developing tumor targeting platform technologies; scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals’ responses to drug treatments; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the fields of oncology, immunology and immuno-oncology; pharmaceutical product development and evaluation services; pharmaceutical research and development; technical research in the field of pharmaceutical studies; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services in the fields of biotechnology and pharmaceutical research; consulting services for others in the field of design, planning, and implementation of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of cancerous diseases; pharmaceutical services; pharmaceutical advisory services; laboratory analysis services relating to the treatment of persons; laboratory analysis services relating to the diagnosis and treatment of cancerous diseases; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology.
Licensing of intellectual property rights; licensing of industrial property rights.
UK00003568803
Word
Individual